特异性-话题@MedSci

#特异性#

563篇内容 | 2162人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1899405, encodeId=2d1118994051c, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Nature：太迷了…Nature研究：未感染人群体内也能检出新冠病毒特异性免疫T细胞, objectType=article, longId=197843, objectId=d26d19e843d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d26d19e843d6, replyNumber=0, likeNumber=36, createdTime=2021-03-08, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d26d19e843d6, moduleTitle=Nature：太迷了…Nature研究：未感染人群体内也能检出新冠病毒特异性免疫T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d26d19e843d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899362, encodeId=0df01899362df, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=肺癌新疗法！“双特异性疗法”获美国FDA突破性药物资格！, objectType=article, longId=189972, objectId=ad4b1899e2fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad4b1899e2fc, replyNumber=0, likeNumber=54, createdTime=2020-11-11, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad4b1899e2fc, moduleTitle=肺癌新疗法！“双特异性疗法”获美国FDA突破性药物资格！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad4b1899e2fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899391, encodeId=029a189939101, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Circulation：免疫蛋白酶体抑制剂可减轻自体免疫相关性心肌炎的心脏特异性免疫反应, objectType=article, longId=195871, objectId=ec211958e16b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec211958e16b, replyNumber=0, likeNumber=48, createdTime=2020-09-23, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec211958e16b, moduleTitle=Circulation：免疫蛋白酶体抑制剂可减轻自体免疫相关性心肌炎的心脏特异性免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec211958e16b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899446, encodeId=647e1899446e4, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Eur Urol：前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像对前列腺癌是否划算？ , objectType=article, longId=205101, objectId=99d920510109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99d920510109, replyNumber=0, likeNumber=68, createdTime=2021-10-25, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99d920510109, moduleTitle=Eur Urol：前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像对前列腺癌是否划算？ , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99d920510109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899368, encodeId=aa4f18993685d, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Medrxiv：新冠肺炎特异性抗体可长期存在，老年人的含量明显高于年轻人, objectType=article, longId=191851, objectId=c05b191851a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c05b191851a7, replyNumber=0, likeNumber=58, createdTime=2020-08-31, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c05b191851a7, moduleTitle=Medrxiv：新冠肺炎特异性抗体可长期存在，老年人的含量明显高于年轻人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c05b191851a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899433, encodeId=93941899433c0, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=World Allergy Organ J：鼻对Der p的特异性IgE筛选测试不能预测非过敏性鼻炎患者鼻腔挑战试验结果 , objectType=article, longId=202312, objectId=3ae620231255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ae620231255, replyNumber=0, likeNumber=54, createdTime=2021-05-17, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ae620231255, moduleTitle=World Allergy Organ J：鼻对Der p的特异性IgE筛选测试不能预测非过敏性鼻炎患者鼻腔挑战试验结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ae620231255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899369, encodeId=22f41899369c7, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=再生元与再鼎医药合作开发REGN1979（CD20xCD3双特异性抗体），治疗非霍奇金淋巴瘤, objectType=article, longId=191863, objectId=981f191863d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981f191863d9, replyNumber=0, likeNumber=57, createdTime=2020-11-09, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981f191863d9, moduleTitle=再生元与再鼎医药合作开发REGN1979（CD20xCD3双特异性抗体），治疗非霍奇金淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981f191863d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899393, encodeId=7c7118993934a, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Med Sci Sports Exerc：运动强度在慢性非特异性腰痛康复中的重要性, objectType=article, longId=196162, objectId=a176196162aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a176196162aa, replyNumber=0, likeNumber=73, createdTime=2020-09-24, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a176196162aa, moduleTitle=Med Sci Sports Exerc：运动强度在慢性非特异性腰痛康复中的重要性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a176196162aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899355, encodeId=29321899355f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, objectType=article, longId=187870, objectId=4a7018e87076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7018e87076, replyNumber=0, likeNumber=63, createdTime=2020-05-30, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7018e87076, moduleTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7018e87076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899417, encodeId=f166189941e93, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Sci Transl Med ：“双特异性抗体”助力PD-1阻断免疫疗法，抗肿瘤免疫更强更持久！, objectType=article, longId=199580, objectId=491e19958078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=491e19958078, replyNumber=0, likeNumber=50, createdTime=2020-09-06, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=491e19958078, moduleTitle=Sci Transl Med ：“双特异性抗体”助力PD-1阻断免疫疗法，抗肿瘤免疫更强更持久！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=491e19958078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899401, encodeId=4e16189940193, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=罗氏CD20xCD3双特异性抗体Mosunetuzumab治疗滤泡性淋巴瘤，获得FDA的突破性治疗指定, objectType=article, longId=197588, objectId=c63a19e588ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c63a19e588ba, replyNumber=0, likeNumber=59, createdTime=2021-02-12, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c63a19e588ba, moduleTitle=罗氏CD20xCD3双特异性抗体Mosunetuzumab治疗滤泡性淋巴瘤，获得FDA的突破性治疗指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c63a19e588ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899352, encodeId=b27f18993523a, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Int J Biol Sci：可溶性CD83能够通过调节抗原特异性Th2细胞特性来减轻试验性过敏性鼻炎, objectType=article, longId=186767, objectId=e56f186e67cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56f186e67cb, replyNumber=0, likeNumber=112, createdTime=2020-04-05, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56f186e67cb, moduleTitle=Int J Biol Sci：可溶性CD83能够通过调节抗原特异性Th2细胞特性来减轻试验性过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56f186e67cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899413, encodeId=1682189941333, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=AGING CELL：只需给药四天，Cdc42特异性抑制剂可延长寿命, objectType=article, longId=198877, objectId=8ed81988e7d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ed81988e7d5, replyNumber=0, likeNumber=0, createdTime=2021-01-31, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ed81988e7d5, moduleTitle=AGING CELL：只需给药四天，Cdc42特异性抑制剂可延长寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ed81988e7d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899376, encodeId=dd6d18993e604, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查 , objectType=article, longId=193105, objectId=db55193105ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db55193105ab, replyNumber=0, likeNumber=61, createdTime=2020-12-04, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db55193105ab, moduleTitle=Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db55193105ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899354, encodeId=05b11899354fb, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎, objectType=article, longId=187666, objectId=60c818e6662e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60c818e6662e, replyNumber=0, likeNumber=66, createdTime=2020-02-20, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60c818e6662e, moduleTitle=Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60c818e6662e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899428, encodeId=06131899428b8, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Papillomavirus Res：宫颈阴道分泌物中感染和疫苗诱导的HPV特异性抗体, objectType=article, longId=201333, objectId=91f1201333b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91f1201333b9, replyNumber=0, likeNumber=59, createdTime=2021-04-10, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91f1201333b9, moduleTitle=Papillomavirus Res：宫颈阴道分泌物中感染和疫苗诱导的HPV特异性抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91f1201333b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899395, encodeId=9cd91899395bf, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=中国双特异性抗体的开发：概况与展望, objectType=article, longId=196662, objectId=91e819666220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91e819666220, replyNumber=0, likeNumber=59, createdTime=2021-02-21, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91e819666220, moduleTitle=中国双特异性抗体的开发：概况与展望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91e819666220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899416, encodeId=89c4189941657, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Cell：滴血检测肿瘤将成为可能！特异性达到90%以上, objectType=article, longId=199525, objectId=ea57199525e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea57199525e8, replyNumber=0, likeNumber=55, createdTime=2020-10-12, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea57199525e8, moduleTitle=Cell：滴血检测肿瘤将成为可能！特异性达到90%以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea57199525e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899409, encodeId=f3811899409ef, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=Gut：深度解读！为何机体肠道免疫反应也具有位点特异性？, objectType=article, longId=198145, objectId=506a19814538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=506a19814538, replyNumber=0, likeNumber=66, createdTime=2021-06-23, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=506a19814538, moduleTitle=Gut：深度解读！为何机体肠道免疫反应也具有位点特异性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=506a19814538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1899388, encodeId=cb661899388eb, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, objectTitle=CAR-T细胞疗法和双特异性抗体再发力：罗氏与信达生物签署20亿美元合作协议, objectType=article, longId=195728, objectId=ce9d195e287e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce9d195e287e, replyNumber=0, likeNumber=77, createdTime=2021-05-17, rootId=0, userName=jinweidong, userId=dc7a157, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce9d195e287e, moduleTitle=CAR-T细胞疗法和双特异性抗体再发力：罗氏与信达生物签署20亿美元合作协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce9d195e287e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

特异性

2020-05-29

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Nature：太迷了…Nature研究：未感染人群体内也能检出新冠病毒特异性免疫T细胞

2021-03-08

jinweidong (审核中...)

前往app查看评论内容

#特异性#

肺癌新疗法！“双特异性疗法”获美国FDA突破性药物资格！

2020-11-11

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Circulation：免疫蛋白酶体抑制剂可减轻自体免疫相关性心肌炎的心脏特异性免疫反应

2020-09-23

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Eur Urol：前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像对前列腺癌是否划算？

2021-10-25

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Medrxiv：新冠肺炎特异性抗体可长期存在，老年人的含量明显高于年轻人

2020-08-31

jinweidong (审核中...)

前往app查看评论内容

#特异性#

World Allergy Organ J：鼻对Der p的特异性IgE筛选测试不能预测非过敏性鼻炎患者鼻腔挑战试验结果

2021-05-17

jinweidong (审核中...)

前往app查看评论内容

#特异性#

再生元与再鼎医药合作开发REGN1979（CD20xCD3双特异性抗体），治疗非霍奇金淋巴瘤

2020-11-09

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Med Sci Sports Exerc：运动强度在慢性非特异性腰痛康复中的重要性

2020-09-24

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长

2020-05-30

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Sci Transl Med ：“双特异性抗体”助力PD-1阻断免疫疗法，抗肿瘤免疫更强更持久！

2020-09-06

jinweidong (审核中...)

前往app查看评论内容

#特异性#

罗氏CD20xCD3双特异性抗体Mosunetuzumab治疗滤泡性淋巴瘤，获得FDA的突破性治疗指定

2021-02-12

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Int J Biol Sci：可溶性CD83能够通过调节抗原特异性Th2细胞特性来减轻试验性过敏性鼻炎

2020-04-05

jinweidong (审核中...)

前往app查看评论内容

#特异性#

AGING CELL：只需给药四天，Cdc42特异性抑制剂可延长寿命

2021-01-31

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Prostate Cancer P D：共享决策和基于前列腺特异性抗原的前列腺癌筛查

2020-12-04

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Int J Pharm：CD13特异性配体能够促进苍儿素纳米药物靶向树突细胞来治疗难治性过敏性鼻炎

2020-02-20

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Papillomavirus Res：宫颈阴道分泌物中感染和疫苗诱导的HPV特异性抗体

2021-04-10

jinweidong (审核中...)

前往app查看评论内容

#特异性#

中国双特异性抗体的开发：概况与展望

2021-02-21

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Cell：滴血检测肿瘤将成为可能！特异性达到90%以上

2020-10-12

jinweidong (审核中...)

前往app查看评论内容

#特异性#

Gut：深度解读！为何机体肠道免疫反应也具有位点特异性？

2021-06-23

jinweidong (审核中...)

前往app查看评论内容

#特异性#

CAR-T细胞疗法和双特异性抗体再发力：罗氏与信达生物签署20亿美元合作协议

2021-05-17

科室
- - 订阅+
  - 更多科室
工具
服务